An Evaluation of the Biosense 2.0 “Poisoning by Medicines” Syndrome Using Chief-Complaint Data in Utah by Burke, Anne et al.
ISDS Annual Conference Proceedings 2014. This is an Open Access article distributed under the terms of the Creative Commons Attribution-
Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
ISDS 2014 Conference Abstracts
An Evaluation of the Biosense 2.0 “Poisoning by 
Medicines” Syndrome Using Chief-Complaint Data in 
Utah
Anne Burke*, David Jackson and Allyn K. Nakashima
Bureau of Epidemiology, Utah Department of Health, Salt Lake City, UT, USA
Objective
To evaluate the BioSense 2.0 “poisoning by medicines” syndrome 
by determining chief complaint terms for inclusion and exclusion 
based upon pre-defined ICD-9 codes and a comparison of binned and 
unbinned chief complaint data.
Introduction
BioSense 2.0 uses predetermined syndromes based upon ICD-9 
codes and chief complaint data to allow users to view and analyze 
data from emergency department (ED) visits, yet further validations 
of these syndromes are needed. Previous studies have validated 
syndromic surveillance syndromes by comparing chief complaint 
data to discharge diagnosis;1,2 however, these efforts are not possible 
for jurisdictions in which facilities do not submit ICD-9 code data. 
Currently in Utah, the syndromic surveillance data submitted includes 
only chief complaint information. Thus, efforts to validate BioSense 
syndromes, such the “poisoning by medicines” syndrome, can be 
informed by but not analyzed in accordance with ICD-9 code and 
discharge diagnosis data in Utah.
Methods
ICD-9 codes included in the BioSense 2.0 syndrome were examined 
to create a working definition for the “poisoning by medicines” 
syndrome. BioSense 2.0 was utilized to generate a list of all-cause 
ED visits for one year prior to the day of study initiation (July 1, 2014) 
from participating Utah hospitals (N=20). Terms for inclusion and 
exclusion were defined using iterative processes. Groups of reviewers 
consisting of the local and state health department epidemiologists and 
BioSense users convened to discuss potential search terms. Searches 
of the all-cause ED visits were completed using these terms while 
new terms continued to be determined. The cycle of determination of 
terms for inclusion continued until no new terms were established. All 
visits binned to the BioSense 2.0 “poisoning by medicines” syndrome 
were reviewed for validity and terms for exclusion were determined. 
A paired t-test was conducted to compare the number of ED visits 
binned to the “poisoning by medicines” syndrome using the initial 
and revised definitions.
Results
Review of the ICD-9 codes binned to the “poisoning by medicines” 
syndrome suggested that chief complaints for poisoning by drugs, 
medicinials, and biological substances should be included for 
visits which are accidental, intentional, assault, or of undetermined 
intention. Important terms for inclusion not previously binned to the 
syndrome included “od,” “overmedicated,” and “ingested.” Important 
terms for exclusion were identified which pertained to ED visits for 
alcohol, carbon monoxide, and food poisoning; swallowing a foreign 
body; and contact dermatitis, but not ED visits for drug, medicinals, 
and biological substance overdose. Overall, 909 and 3,073 visits 
were excluded and included from binning by these new criteria, 
respectively. The mean number of visits for “poisoning by medicines” 
per day increased significantly with the revised definition (t=27.1149; 
p<0.0001).
Conclusions
The results of this study suggest that in the absence of ICD-9 code 
data, review of binned and unbinned chief complaint data may suggest 
terms for inclusion and exclusion for BioSense 2.0 syndromes. 
Overall, the initial BioSense 2.0 “poisoning by medicines” syndrome 
underestimated the amount of visits for this chief complaint. The 
results of this analysis are specific to hospitals reporting syndromic 
surveillance in Utah. Efforts to on-board facilities in Utah are ongoing. 
Other locations may use different chief complaint terminology to 
describe ED visits for “poisoning by medicines” and these results 
may not be generalizable to other facilities and locations. Reviewing 
binned and unbinned chief complaint data may help to ensure 
data quality and allow for greater accuracy when using syndromic 
surveillance data to monitor the health of the population.
Table 1. Chief complaint terms for inclusion and exclusion in the “poisoning 
by medicines” syndrome
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